Immune cell infiltration in head and neck squamous cell carcinoma and patient outcome: a retrospective study

References

• Gillison ML, Alemany L, Snijders PJ, et al. Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis. Vaccine. 2012;30 Suppl 5:F34–F54.
   PubMed Web of Science ®Google Scholar
• Gooi Z, Chan JY, Fakhry C. The epidemiology of the human papillomavirus related to oropharyngeal head and neck cancer. Laryngoscope. 2016;126:894–900.
   PubMed Web of Science ®Google Scholar
• Olthof NC, Straetmans JM, Snoeck R, et al. Next-generation treatment strategies for human papillomavirus-related head and neck squamous cell carcinoma: where do we go?. Rev Med Virol. 2012;22:88–105.
   PubMed Web of Science ®Google Scholar
• Stein AP, Saha S, Kraninger JL, et al. Prevalence of human papillomavirus in oropharyngeal cancer: a systematic review. Cancer J. 2015;21:138–146.
   PubMed Web of Science ®Google Scholar
• Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92:709–720.
   PubMed Web of Science ®Google Scholar
• Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24–35.
   PubMed Web of Science ®Google Scholar
• Sedghizadeh PP, Billington WD, Paxton D, et al. Is p16-positive oropharyngeal squamous cell carcinoma associated with favorable prognosis? A systematic review and meta-analysis. Oral Oncol. 2016;54:15–27.
   PubMed Web of Science ®Google Scholar
• Pagès F, Galon J, Dieu-Nosjean MC, et al. Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene. 2010;29:1093–1102.
   PubMed Web of Science ®Google Scholar
• Mandal R, Şenbabaoğlu Y, Desrichard A, et al. The head and neck cancer immune landscape and its immunotherapeutic implications. JCI Insight. 2016;1:e89829.
   PubMed Web of Science ®Google Scholar
• Green VL, Michno A, Stafford ND, et al. Increased prevalence of tumour infiltrating immune cells in oropharyngeal tumours in comparison to other subsites: relationship to peripheral immunity. Cancer Immunol Immunother. 2013;62:863–873.
   PubMed Web of Science ®Google Scholar
• Kong CS, Narasimhan B, Cao H, et al. The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys. 2009;74:553–561.
   PubMed Web of Science ®Google Scholar
• Ward MJ, Thirdborough SM, Mellows T, et al. Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer. Br J Cancer. 2014;110:489–500.
   PubMed Web of Science ®Google Scholar
• Wansom D, Light E, Thomas D, et al. Infiltrating lymphocytes and human papillomavirus-16-associated oropharyngeal cancer. Laryngoscope. 2012;122:121–127.
   PubMed Web of Science ®Google Scholar
• Rittà M, Landolfo V, Mazibrada J, et al. Human papillomavirus tumor-infiltrating T-regulatory lymphocytes and P53 codon 72 polymorphisms correlate with clinical staging and prognosis of oropharyngeal cancer. New Microbiol. 2013;36:133–144.
   PubMed Web of Science ®Google Scholar
• Nelson BH. CD20+ B cells: the other tumor-infiltrating lymphocytes. J Immunol. 2010;185:4977–4982.
   PubMed Web of Science ®Google Scholar
• Pretscher D, Distel LV, Grabenbauer GG, et al. Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma. BMC Cancer. 2009;9:292.
   PubMed Web of Science ®Google Scholar
• Russell S, Angell T, Lechner M, et al. Immune cell infiltration patterns and survival in head and neck squamous cell carcinoma. Head Neck Oncol. 2013;5:24
   PubMedGoogle Scholar
• Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140:883–899.
   PubMed Web of Science ®Google Scholar
• Bingle L, Brown NJ, Lewis CE. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol. 2002;196:254–265.
   PubMed Web of Science ®Google Scholar
• Petruzzi MN, Cherubini K, Salum FG, et al. Role of tumour-associated macrophages in oral squamous cells carcinoma progression: an update on current knowledge. Diagn Pathol. 2017;12:32.
   PubMed Web of Science ®Google Scholar
• Weynand B, Delvenne P, Polet R, et al. Validation of ThermoFisher's Papspin for human papillomavirus detection in cervicovaginal specimens using PCR with GP5+/GP6+ primers and the Hybrid Capture II assay. Clin Microbiol Infect. 2010;16:671–675.
   PubMed Web of Science ®Google Scholar
• Bouzin C, Saini ML, Khaing KK, et al. Digital pathology: elementary, rapid and reliable automated image analysis. Histopathology. 2016;68:888–896.
   PubMed Web of Science ®Google Scholar
• Hauck F, Oliveira-Silva M, Dreyer JH, et al. Prevalence of HPV infection in head and neck carcinomas shows geographical variability: a comparative study from Brazil and Germany. Virchows Arch. 2015;466:685–693.
   PubMed Web of Science ®Google Scholar
• Henneman R, Van Monsjou HS, Verhagen CV, et al. Incidence changes of human papillomavirus in oropharyngeal squamous cell carcinoma and effects on survival in the Netherlands Cancer Institute, 1980-2009. Anticancer Res. 2015;35:4015–4022.
   PubMed Web of Science ®Google Scholar
• Sayed D, El-Badawy OH, Eldin EN, et al. Is Foxp3 a good marker for regulatory T cells? Egypt J Immunol. 2014;21:1–8.
   PubMedGoogle Scholar
• Nguyen N, Bellile E, Thomas D, et al. Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma. Head Neck. 2016;38:1074–1084.
   PubMed Web of Science ®Google Scholar
• Näsman A, Romanitan M, Nordfors C, et al. Tumor infiltrating CD8+ and Foxp3+ lymphocytes correlate to clinical outcome and human papillomavirus (HPV) status in tonsillar cancer. PLoS One. 2012;7:e38711.
   PubMed Web of Science ®Google Scholar
• Jung AC, Guihard S, Krugell S, et al. CD8-alpha T-cell infiltration in human papillomavirus-related oropharyngeal carcinoma correlates with improved patient prognosis. Int J Cancer. 2013;132:E26–E36.
   PubMed Web of Science ®Google Scholar
• Lei Y, Xie Y, Tan YS, et al. Telltale tumor infiltrating lymphocytes (TIL) in oral, head & neck cancer. Oral Oncol. 2016;61:159–165.
   PubMed Web of Science ®Google Scholar
• Maxwell JH, Kumar B, Feng FY, et al. Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence. Clin Cancer Res. 2010;16:1226–1235.
   PubMed Web of Science ®Google Scholar
• Tinhofer I, Jöhrens K, Keilholz U, et al. Contribution of human papilloma virus to the incidence of squamous cell carcinoma of the head and neck in a European population with high smoking prevalence. Eur J Cancer. 2015;51:514–521.
   PubMed Web of Science ®Google Scholar
• Xu Q, Wang C, Yuan X, et al. Prognostic value of tumor-infiltrating lymphocytes for patients with head and neck squamous cell carcinoma. Transl Oncol. 2017;10:10–16.
   PubMed Web of Science ®Google Scholar
• Heusinkveld M, Goedemans R, Briet RJ, et al. Systemic and local human papillomavirus 16-specific T-cell immunity in patients with head and neck cancer. Int J Cancer. 2012;131:E74–E85.
   PubMed Web of Science ®Google Scholar
• Andrade MC, Ferreira SB, Gonçalves LC, et al. Cell surface markers for T and B lymphocytes activation and adhesion as putative prognostic biomarkers for head and neck squamous cell carcinoma. Hum Immunol. 2013;74:1563–1574.
   PubMed Web of Science ®Google Scholar
• Wirsing AM, Rikardsen OG, Steigen SE, et al. Characterisation and prognostic value of tertiary lymphoid structures in oral squamous cell carcinoma. BMC Clin Pathol. 2014;14:38.
   PubMedGoogle Scholar
• Wood O, Woo J, Seumois G, et al. Gene expression analysis of TIL rich HPV-driven head and neck tumors reveals a distinct B-cell signature when compared to HPV independent tumors. Oncotarget. 2016;7:56781–56797.
   PubMedGoogle Scholar